Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.28 Insider Own3.43% Shs Outstand177.58M Perf Week-8.99%
Market Cap293.54M Forward P/E- EPS next Y-0.11 Insider Trans0.28% Shs Float174.97M Perf Month-4.71%
Income-49.78M PEG- EPS next Q-0.02 Inst Own77.62% Short Float / Ratio3.46% / 4.94 Perf Quarter-1.22%
Sales153.63M P/S1.91 EPS this Y9.37% Inst Trans-0.36% Short Interest6.05M Perf Half Y-36.22%
Book/sh0.27 P/B6.09 EPS next Y50.57% ROA-23.64% Target Price4.12 Perf Year-59.40%
Cash/sh0.44 P/C3.72 EPS next 5Y- ROE-82.09% 52W Range1.21 - 4.25 Perf YTD-55.62%
Dividend- P/FCF- EPS past 5Y15.42% ROI-40.79% 52W High-61.88% Beta1.25
Dividend %- Quick Ratio1.35 Sales past 5Y27.14% Gross Margin55.31% 52W Low34.44% ATR0.12
Employees309 Current Ratio1.88 Sales Q/Q0.51% Oper. Margin-44.52% RSI (14)49.78 Volatility8.44% 7.26%
OptionableYes Debt/Eq1.97 EPS Q/Q16.08% Profit Margin-32.41% Rel Volume0.93 Prev Close1.62
ShortableYes LT Debt/Eq1.53 EarningsNov 02 AMC Payout- Avg Volume1.23M Price1.62
Recom1.80 SMA20-3.31% SMA506.92% SMA200-24.70% Volume1,145,453 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-20-23Downgrade BTIG Research Buy → Neutral
Jan-17-23Downgrade Stephens Overweight → Equal-Weight $3.75
Oct-08-20Resumed BTIG Research Buy $9
Jun-16-20Resumed Cantor Fitzgerald Overweight $9
Feb-26-20Initiated BTIG Research Buy $7
Nov-13-19Upgrade BTIG Research Neutral → Buy $7
Aug-28-19Initiated Stifel Buy
Aug-23-19Resumed Stephens Overweight
Jan-05-18Resumed Cantor Fitzgerald Overweight
Dec-08-17Resumed BTIG Research Neutral
Nov-03-23 09:19AM
Nov-02-23 06:43PM
04:00PM Loading…
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
Jul-31-23 12:36PM
Jul-19-23 08:30AM
05:13PM Loading…
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
11:00AM Loading…
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Aug-12-22 08:00AM
Aug-05-22 01:00PM
Aug-04-22 05:25PM
Jul-28-22 09:48AM
Jul-21-22 08:00AM
Jul-14-22 12:00PM
Jul-13-22 11:37AM
Jul-05-22 05:00PM
Jun-23-22 09:55AM
Jun-14-22 08:00AM
Jun-03-22 09:55AM
May-17-22 05:00AM
May-16-22 09:55AM
May-15-22 08:42AM
May-06-22 02:30AM
May-05-22 05:15PM
May-03-22 08:00AM
Apr-28-22 08:35AM
Apr-25-22 08:00AM
Apr-21-22 08:00AM
Apr-07-22 11:39AM
Feb-25-22 08:00AM
Feb-23-22 10:00AM
Feb-22-22 10:00PM
Feb-08-22 08:00AM
Feb-07-22 04:05PM
Feb-04-22 05:36AM
Jan-28-22 01:38PM
Jan-10-22 08:00AM
Dec-28-21 10:00AM
Dec-06-21 04:43AM
Nov-24-21 10:00AM
Nov-19-21 08:00AM
Nov-10-21 11:43AM
Nov-08-21 10:06AM
Nov-03-21 12:03PM
Nov-02-21 05:25PM
Oct-29-21 08:47AM
Oct-26-21 03:02PM
Oct-19-21 08:00AM
Oct-18-21 12:26PM
Oct-07-21 06:49AM
Oct-01-21 08:00AM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucena AnnDirectorAug 22Buy1.697,50012,63872,284Aug 23 06:11 PM
BJERKHOLT ERICDirectorAug 21Buy1.7210,00017,151132,133Aug 23 06:08 PM
Swisher Daniel N JRDirectorMay 26Buy1.915,0009,535118,808May 30 03:45 PM
SCHULZE GAILDirectorMay 24Buy2.039,85019,98183,420May 24 07:18 PM
BJERKHOLT ERICDirectorMay 23Buy2.005,00010,00082,133May 23 05:57 PM
Greenman William MarinerPresident and CEOMar 13Sale2.8060,480169,3442,616,411Mar 14 07:47 PM
Jayaraman Vivek KChief Operating OfficerMar 13Sale2.8025,35670,997641,861Mar 14 07:56 PM
Benjamin Richard JChief Medical OfficerMar 13Sale2.7925,35370,781346,519Mar 14 07:34 PM
Green Kevin DennisChief Financial OfficerMar 13Sale2.8017,16348,056421,797Mar 14 07:43 PM
Menard ChrystalChief Legal OfficerMar 13Sale2.8015,46843,310338,621Mar 14 07:50 PM
CORASH LAURENCE MChief Scientific OfficerMar 13Sale2.8015,34242,9582,250,579Mar 14 07:38 PM
Moore CarolSVP Reg. & QualityMar 13Sale2.8013,07836,618407,598Mar 14 08:00 PM